Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
暂无分享,去创建一个
C. Stroh | H. Hug | A. Mackiewicz | K. Benedyk | C. Burek | M. Los
[1] C. Stroh,et al. The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells , 2002 .
[2] R. Pope. Apoptosis as a therapeutic tool in rheumatoid arthritis , 2002, Nature Reviews Immunology.
[3] John Calvin Reed,et al. Apoptosis-based therapies , 2002, Nature Reviews Drug Discovery.
[4] C. Sawyers. Rational therapeutic intervention in cancer: kinases as drug targets. , 2002, Current opinion in genetics & development.
[5] R. Moritz,et al. HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.
[6] Yuri Lazebnik,et al. Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction* , 2002, The Journal of Biological Chemistry.
[7] E. Schattner. Apoptosis in Lymphocytic Leukemias and Lymphomas , 2002, Cancer investigation.
[8] J. Adams,et al. Proteasome inhibition in cancer: development of PS-341. , 2001, Seminars in oncology.
[9] A. Cochran,et al. Protein-protein interfaces: mimics and inhibitors. , 2001, Current opinion in chemical biology.
[10] M. Gleave,et al. A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] P. Branton,et al. The role of adenovirus E4orf4 protein in viral replication and cell killing , 2001, Oncogene.
[12] I. Enyedy,et al. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.
[13] C. Stroh,et al. The emerging role of caspases in signal transduction as revealed by knock‐out studies − not only apoptosis , 2001 .
[14] C. Chuong,et al. D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. , 2001, Current cancer drug targets.
[15] H. Nakayama,et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.
[16] M. Harding,et al. ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs , 2001, Expert opinion on investigational drugs.
[17] J. Bradbury. TRAIL leads to apoptosis in acute promyelocytic leukaemia , 2001, The Lancet.
[18] L. Altucci,et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL , 2001, Nature Medicine.
[19] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[20] Christopher I. Bayly,et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Vaux,et al. Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis. , 2001, Journal of cell science.
[22] K. Valentino,et al. Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury. , 2001, The Journal of pharmacology and experimental therapeutics.
[23] D. Banerjee. Genasense (Genta Inc). , 2001, Current opinion in investigational drugs.
[24] T. Tuschl,et al. RNA Interference and Small Interfering RNAs , 2001, Chembiochem : a European journal of chemical biology.
[25] Young Chul Park,et al. Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.
[26] I. H. Engels,et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation , 2001, Oncogene.
[27] A. Harken,et al. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Vaux,et al. Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9 , 2001, The Journal of cell biology.
[29] G M Kasof,et al. Livin, a Novel Inhibitor of Apoptosis Protein Family Member* , 2001, The Journal of Biological Chemistry.
[30] Stephen F. Betz,et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain , 2000, Nature.
[31] W. Hong,et al. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. , 2000, Cancer research.
[32] K. Bhalla,et al. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. , 2000, Blood.
[33] R. Hotchkiss,et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.
[34] A. Strasser,et al. The Role of the Pro‐Apoptotic Bcl‐2 Family Member Bim in Physiological Cell Death , 2000, Annals of the New York Academy of Sciences.
[35] S. Srinivasula,et al. Molecular Determinants of the Caspase-promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway* , 2000, The Journal of Biological Chemistry.
[36] H. Jaeschke,et al. Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice. , 2000, Toxicology and applied pharmacology.
[37] Stephen W. Fesik,et al. NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP* , 2000, The Journal of Biological Chemistry.
[38] D. Nicholson,et al. From bench to clinic with apoptosis-based therapeutic agents , 2000, Nature.
[39] C. Reed,et al. Apoptosis and cancer: strategies for integrating programmed cell death. , 2000, Seminars in hematology.
[40] R. Lotan,et al. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells , 2000, Oncogene.
[41] H. Horvitz,et al. The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. , 2000, Molecular cell.
[42] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[43] S. Srinivasula,et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] A. Hamilton,et al. Peptide and protein recognition by designed molecules. , 2000, Chemical reviews.
[45] M. Konopleva,et al. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. , 2000, Blood.
[46] M. Piccart,et al. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[47] J. Mouiel,et al. Caspase inhibition protects from liver injury following ischemia and reperfusion in rats , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[48] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[49] G. Baxter,et al. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury , 2000, British journal of pharmacology.
[50] John Calvin Reed,et al. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. , 2000, Neoplasia.
[51] J. Martinou,et al. The Bcl-2 protein family. , 2000, Experimental cell research.
[52] B. Evers,et al. Sensitization of human colon cancer cells to trail-mediated apoptosis , 2000, Journal of Gastrointestinal Surgery.
[53] A. Strasser,et al. Apoptosis and cell division. , 2000, Current opinion in cell biology.
[54] Fengzhi Li,et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function , 1999, Nature Cell Biology.
[55] R. Flavell,et al. Caspase knockouts: matters of life and death , 1999, Cell Death and Differentiation.
[56] E. Slee,et al. Serial killers: ordering caspase activation events in apoptosis , 1999, Cell Death and Differentiation.
[57] D. Nicholson,et al. Caspase structure, proteolytic substrates, and function during apoptotic cell death , 1999, Cell Death and Differentiation.
[58] J C Reed,et al. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.
[59] P. Vandenabeele,et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. , 1999, The Journal of clinical investigation.
[60] D. Lawrence,et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.
[61] K. Schulze-Osthoff,et al. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. , 1999, Immunity.
[62] S. Nakamura,et al. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. , 1999, Journal of immunology.
[63] M. Nau,et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. , 1999, Cancer research.
[64] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[65] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[66] Emad S. Alnemri,et al. Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.
[67] S. Korsmeyer,et al. Cell Death in Development , 1999, Cell.
[68] J C Reed,et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. , 1998, Cancer research.
[69] T. Griffith,et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. , 1998, Journal of immunology.
[70] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[71] D. Vaux,et al. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. , 1998, Trends in biochemical sciences.
[72] J C Reed,et al. Bax directly induces release of cytochrome c from isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[73] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[74] G. Fantuzzi,et al. Interleukin-18 Regulation of Interferon γ Production and Cell Proliferation as Shown in Interleukin-1β–Converting Enzyme (Caspase-1)-Deficient Mice , 1998 .
[75] K. Maehara,et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.
[76] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[77] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[78] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[79] J C Reed,et al. Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.
[80] D. Livingston,et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[81] Ping Li,et al. Characterization of mice deficient in interleukin‐1β converting enzyme , 1997 .
[82] G. Gil-Gómez,et al. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. , 1996, The EMBO journal.
[83] A. Strasser,et al. The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.
[84] I. Chaudry,et al. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. , 1996, Blood.
[85] H. Petrie,et al. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death , 1996, The Journal of experimental medicine.
[86] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[87] M. Peter,et al. Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.
[88] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[89] R. Kamen,et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.
[90] Y. S. Lin,et al. Sepsis-induced apoptosis of the thymocytes in mice. , 1994, Journal of immunology.
[91] Shai Shaham,et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.
[92] John Calvin Reed,et al. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.
[93] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[94] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[95] H. Hug,et al. Caspases--their role in apoptosis and other physiological processes as revealed by knock-out studies. , 2002, Archivum immunologiae et therapiae experimentalis.
[96] I. H. Engels,et al. Caspases: more than just killers? , 2001, Trends in immunology.
[97] G. Fantuzzi,et al. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. , 1998, Blood.